Overview

Relative Bioavailability Study to Evaluate Cetirizine HCl Gummy 10 mg and Cetirizine HCl Oral Tablets 10 mg

Status:
Not yet recruiting

Trial end date:
2021-06-30

Target enrollment:

Participant gender:

Summary

A Randomized, Open-Label, Single-Dose, Five-Period Crossover, Relative Bioavailability Study to Evaluate Cetirizine HCl Gummy 10 mg and Cetirizine HCl Oral Tablets 10 mg Administered in Healthy Adult Male and Female Subjects

Phase:

Phase 1

Details

Lead Sponsor:

Seattle Gummy Company

Collaborators:

Frontage Clinical Services, Inc.
Frontage Laboratories, Inc.

Treatments:

Cetirizine